Global Therapeutic Drug Monitoring Market Size & Trends Report Segmented by Product (Equipment, Consumables), Drug Class (Antiepileptics, Immunosuppressants), Therapeutic Area (Cancer, CVDs), End-user (Hospitals, Diagnostic Centers) & Regional Forecast to 2030
The global therapeutic drug monitoring market is expected to grow at a CAGR of around 8% during the forecast period. The market growth is primarily driven by the expansion of personalized medicine, the increasing prevalence of chronic diseases that need long-term pharmacotherapy, and the increased focus on patient safety through optimal drug dosing. The market growth is, however, moderately restrained by the high cost of TDM devices and reduced access in resource-scarce healthcare environments. To learn more about the research report, download a sample report.
Report Overview
Therapeutic Drug Monitoring (TDM) is a clinical application aimed at measuring the concentration of certain drugs in the patient’s blood at specific time intervals. The main goal is to maintain medication in the therapeutic range—sufficient to be beneficial but not enough to result in toxicity. TDM is commenced by sample collection (generally blood sample), then analyzed in the laboratory by using immunoassays or chromatographic techniques. It is very important for individualizing drug treatment regimens with a narrow therapeutic window, maximizing drug efficacy and patient safety.
To learn more about the research report, download a sample report.
Increasing Prevalence of Chronic Diseases Requiring Long-Term Medication
One of the key drivers of the widespread adoption of TDM devices is the global rise in chronic conditions such as cancer, cardiovascular disease, epilepsy and autoimmune diseases, which require frequent monitoring and prolonged treatment with drugs that have narrow therapeutic windows, including immunosuppressants, antiepileptics, and some antibiotics. In these instances, it is important to sustain drug levels in a specified range—both to avoid underdosing and overdosing. Since chronic illnesses require ongoing and accurate dosing over weeks or months, physicians are now relying more on TDM to individualize treatment regimens and improve patient safety. Additionally, the rising geriatric population and the common use of complex drug regimens (mainly in oncology and transplant medicine) have further expanded the clinical relevance of TDM. This emerging medical need is directly correlating with increased demand for monitoring devices and services by hospitals and diagnostic laboratories.
To learn more about the research report, download a sample report.
Integration of Microsampling Techniques in Therapeutic Drug Monitoring
One of the most significant innovations augmenting TDM is the creation of microsampling technologies, including volumetric absorptive microsampling (VAMS) and dried blood spot (DBS) testing. These technologies enable the collection of very small volumes of blood—often a few microliters—via minimally invasive procedures like finger pricks. In contrast to standard venipuncture, microsampling does not involve skilled phlebotomists or large volumes of blood, so it is less invasive for patients and more convenient for outpatient or home settings. Microsampling is particularly valuable with pediatric, geriatric, and rural populations, where standard sampling proves difficult. The less complicated logistics also allow for samples to be taken in non-clinical settings and sent by mail to central labs without requiring cold chain shipping. As a result, microsampling has enhanced the patient compliance and feasibility considerably in standard TDM programs, thus facilitating broader use and increased monitoring in clinical practice.
Competitive Landscape Analysis
The global therapeutic drug monitoring market is marked by the presence of established and emerging market players such as Abbott; ALPCO; Danaher Corporation; Bio-Rad Laboratories, Inc; Thermo Fisher Scientific Inc.; F.Hoffmann-La Roche Ltd.; Randox laboratories Ltd; Siemens Healthineers AG.; biomérieux, Inc. and Chromsystems Instruments & Chemicals GmbH among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
|
Report Scope |
Details |
|
Base Year Considered |
2024 |
|
Historical Data |
2023 - 2024 |
|
Forecast Period |
2025 – 2030 |
|
Growth Rate |
8% |
|
Market Drivers |
|
|
Attractive Opportunities |
|
|
Segment Scope |
Product, Drug Class, Therapeutic Area and End-user |
|
Regional Scope |
|
|
Key Companies Mapped |
Abbott; ALPCO; Danaher Corporation; Bio-Rad Laboratories, Inc; Thermo Fisher Scientific Inc.; F.Hoffmann-La Roche Ltd.; Randox laboratories Ltd; Siemens Healthineers AG.; biomérieux, Inc. and Chromsystems Instruments & Chemicals GmbH among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global therapeutic drug monitoring market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, drug class, therapeutic area and end-user.
- Market Size & Forecast (2023-2030), By Product, USD Million
- Equipment
- Immunoassay Analyzers
- Clinical Chemistry Analyzers
- Chromatography & MS Detectors
- Consumables
- Equipment
- Market Size & Forecast (2023-2030), By Drug Class, USD Million
- Antiepileptic Drugs
- Immunosuppressants
- Antiarrhythmic Drugs
- Others
- Market Size & Forecast (2023-2030), By Therapeutic Area, USD Million
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Others
- Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals
- Diagnostic Centers
- Others
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the therapeutic drug monitoring market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the therapeutic drug monitoring market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Therapeutic Drug Monitoring Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rise in chronic diseases requiring long-term drug therapy
- Growing demand for personalized medicine
- Increasing use of narrow therapeutic index drugs
- Rising geriatric population globally
- Greater emphasis on patient safety and treatment efficacy
- Expansion of hospital and diagnostic lab infrastructure
- Restraints
- High cost of advanced TDM equipment and tests
- Limited availability in resource-constrained settings
- Variability in clinical guidelines across regions
- Opportunities
- Integration of point-of-care devices in clinical workflows
- Expansion of outpatient and home-based monitoring models
- Development of companion diagnostics for specific drug regimens
- Untapped markets in low- and middle-income countries
- Key Market Trends
- Adoption of microsampling and remote testing
- Shift toward non-invasive and patient-centric monitoring
- Drivers
- Market Dynamics
-
- Unmet Market Needs
- Industry Speaks
- Global Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Equipment
- Immunoassay Analyzers
- Clinical Chemistry Analyzers
- Chromatography & MS Detectors
- Consumables
- Global Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), By Drug Class, USD Million
- Introduction
- Antiepileptic Drugs
- Immunosuppressants
- Antiarrhythmic Drugs
- Others
- Global Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), By Therapeutic Area, USD Million
- Introduction
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Others
- Global Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospitals
- Diagnostic Centers
- Others
- Global Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Latin America (LATAM) Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Therapeutic Drug Monitoring Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Drug Class (USD Million)
- Market Size & Forecast, By Therapeutic Area (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Abbott
- ALPCO
- Danaher Corporation
- Bio-Rad Laboratories, Inc
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd.
- Randox Laboratories Ltd
- Siemens Healthineers AG.
- Biomerieux, Inc
- Chromsystems Instruments & Chemicals GmbH
- Other Prominent Players
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Diagnostic Centers and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
